SCHEMBL7087904

SCHEMBL7087904

O=CN(CO)Cc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.41
ALDH1A1 P00352 2/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
CA12 O43570 1/20 0.41
CA9 Q16790 1/20 0.41
HPGD P15428 1/20 0.41
TDP1 Q9NUW8 2/20 0.41
LMNA P02545 1/20 0.40
CA2 P00918 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
AOC3 Q16853 1/20 0.39
MEN1 O00255 1/20 0.39
HTT P42858 1/20 0.39
KMT2A Q03164 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
REN P00797 1/20 0.39
MGLL Q99685 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26802 0.87 ALDH1A1 (0.48) TSHRALDH1A1NPC1RAB9ACA12
SCHEMBL6770221 0.84 CES2 (0.43) TSHRALDH1A1NPC1RAB9ACA12
SCHEMBL9827242 0.84 HTT (0.42) TSHRALDH1A1NPC1RAB9ACA12
Malonic Acid SCHEMBL16431221 0.80 NPC1 (0.47) TSHRALDH1A1NPC1RAB9ACA12
SCHEMBL968495 0.79 LMNA (0.48) TSHRALDH1A1NPC1RAB9ACA12
SCHEMBL28028840 0.79 ALDH1A1 (0.42) TSHRALDH1A1NPC1RAB9ACA12
SCHEMBL28517819 0.79 MEN1 (0.46) TSHRALDH1A1NPC1RAB9ACA12
SCHEMBL13723128 0.78 HDAC2 (0.42) REN
SCHEMBL5522932 0.78 TAAR1 (0.47) TSHRALDH1A1NPC1RAB9ATDP1
SCHEMBL5522934 0.78 TAAR1 (0.47) TSHRALDH1A1NPC1RAB9ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0668860-B1 PYRAN-2-ONES AND 5,6-DIHYDROPYRAN-2-ONES USEFUL FOR TREATING HIV AND OTHER RETROVIRUSES UPJOHN CO (US) 2002-09-11 EP claimed
US-20030176477-A1 Isothiazolecarboxylic acid derivatives and their use as microbicides NIHON BAYER AGROCHEM, K.K. (JP) 2003-09-18 US disclosed
CN-1420875-A Isothiazolecarboxylic acid derivs. and their use as microbicides BAYER AGROCHEM KK (JP) 2003-05-28 CN disclosed
EP-1261592-A1 ISOTHIAZOLECARBOXYLIC ACID DERIVATIVES AND THEIR USE AS MICROBICIDES NIHON BAYER AGROCHEM K.K. (JP) 2002-12-04 EP disclosed
EP-1203770-A1 Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hyperplasia and other diseases PHARMACIA & UPJOHN COMPANY (US) 2002-05-08 EP disclosed
WO-2001055124-A1 ISOTHIAZOLECARBOXYLIC ACID DERIVATIVES AND THEIR USE AS MICROBICIDES NIHON BAYER AGROCHEM K.K. (JP) 2001-08-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030176477-A1 Isothiazolecarboxylic acid derivatives and their use as microbicides IFNG, MPO, CD14 TSHR 3745/4885ALDH1A1 430/4885NPC1 1277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.